SCHEMBL21592671

SCHEMBL21592671

CN1CCCN(c2ccc(-c3cnc4[nH]cc(-c5ccc(C(=O)N(C)C)cc5)c4c3)cc2C#N)CC1

nearest known ligand 0.55

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
MAP4K1 Q92918 7/20 0.55
TNIK Q9UKE5 6/20 0.53
MAP3K11 Q16584 3/20 0.49
CYP3A4 P08684 2/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2D6 P10635 1/20 0.46
TSHR P16473 1/20 0.46
HIF1A Q16665 1/20 0.44
CLK4 Q9HAZ1 1/20 0.44
ROCK2 O75116 1/20 0.44
ROCK1 Q13464 1/20 0.44
CDC42BPA Q5VT25 1/20 0.44
CDC42BPB Q9Y5S2 1/20 0.44
IL2 P60568 2/20 0.44
SGK1 O00141 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21592605 0.97 MAP4K1 (0.58) MAP4K1TNIKMAP3K11CYP3A4CYP1A2
SCHEMBL21592685 0.91 MAP3K11 (0.47) MAP4K1TNIKMAP3K11ROCK2ROCK1
SCHEMBL28502217 0.90 MAP4K1 (0.59) MAP4K1TNIKMAP3K11CYP3A4CYP1A2
SCHEMBL21592875 0.89 MAP4K1 (0.56) MAP4K1TNIKMAP3K11CYP3A4CYP1A2
SCHEMBL21592598 0.89 MAP4K1 (0.56) MAP4K1TNIKMAP3K11CYP3A4CYP1A2
SCHEMBL28905284 0.88 SGK1 (0.57) MAP4K1TNIKMAP3K11IL2SGK1
SCHEMBL21592556 0.87 MAP4K1 (0.62) MAP4K1TNIKMAP3K11
SCHEMBL21592821 0.86 TNIK (0.55) MAP4K1TNIKMAP3K11IL2
SCHEMBL28503521 0.86 TNIK (0.53) MAP4K1TNIKMAP3K11ROCK2ROCK1
SCHEMBL28507510 0.86 MAP4K1 (0.53) MAP4K1TNIKMAP3K11CYP3A4CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019238067-A1 PYRROLO [2, 3-B] PYRIDINES OR PYRROLO [2, 3-B] PYRAZINES AS HPK1 INHIBITOR AND THE USE THEREOF BEIGENE, LTD. (KY) 2019-12-19 WO disclosed